These results, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two guidance the thought of targeting ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant disorders. By ticking this box and submitting https://harrisony394ntb7.blog2news.com/profile